Couldn't agree more. This is horrifying. Appreciate there aren't easy solutions but vast improvements are needed.

We will also be starting our Audit and Feedback process & we encourage all providers in England to review their data completeness for the CNS data item or the results for "proportion of people diagnosed with kidney cancer that were seen by a CNS" on our data dashboard rcs-ceu.shinyapps.io/NKCA/

it's the launch of the NICE guideline www.nice.org.uk/guidance/ng256 & quality standard www.nice.org.uk/guidance/qs215 for kidney cancer which include guidance on Clinical Nurse Specialist care.

The audit's QI intervention www.natcan.org.uk/nkca-quality... is aiming to improve access to CNS care.

It's a big Quality Improvement day for my audits today.

At 9am, @npca-natcan.bsky.social is hosting a webinar www.natcan.org.uk/events/webin... as part of our QI intervention www.natcan.org.uk/quality-impr.... It will be recorded so you can watch back.

And today in the @nkca-natcan.bsky.social...

World's longest coastal path opens in England to the public The King Charles coastal path will allow walkers right of access to the entire coast for the first time.

This is absolutely brilliant. Instigated by Gordon Brown, delivered today. www.bbc.co.uk/news/article...

It's #NationalCancerCNSDay!
NKCA is working to improve access to CNS support through a new Quality Improvement intervention.

💡Find more on our website:
buff.ly/3xcrp8P
📊Check your trust’s data on our data dashboard: buff.ly/jDx7KjX

@ukons.bsky.social
@baunnurses.bsky.social

Congratulations to Arjun for this important paper.

Read, share and follow @npca-natcan.bsky.social for news/papers from the National Prostate Cancer Audit, plenty more to come!

OpenSAFELY news: you can apply to do non-COVID research, from today! | Bennett Institute for Applied Data Science We are delighted to announce that - from today - you can submit applications to the OpenSAFELY service for non-COVID-19 studies.

OpenSAFELY is open from today! Huge thanks to all who supported this vast collaboration: whole population GP data; in a productive platform; innovative privacy protections; unprecedented support from professions, privacy campaigners; &c

Now it's over to users!

www.bennett.ox.ac.uk/blog/2026/02...

Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine

In this Review, Alice Bernard-Tessier & @mishabeltran.bsky.social discuss the underlying biology in mHSPC and highlight current knowledge gaps: doi.org/10.1172/JCI2...

Very clear thread, well worth reading and sharing.

lab to life

Exciting conference alert!

sites.manchester.ac.uk/from-lab-to-...

Fantastic speakers including Chris Marine, Christian Blank

Melanoma evolution
Local microenvironment of melanoma
Melanoma-host interactions
Precision immunotherapy
Emerging therapeutics
Clinical trials and real-world data

🔔3 Days to Go!
Join Us for the NATCAN Webinar at @londonglobalcancer.bsky.social

📅 Thursday, 27 November
🕙 10:30 AM – 12:00 PM (GMT)

Last chance to register: natcan.org.uk/events/londo...

#LGCW2025 #LondonGlobalCancerWeek

MI/25/63 Associate Scientist | Cancer Research UK Manchester Institute We are seeking a highly motivated and accomplished Associate Scientist to help lead and shape the programme. You will act as an operational deputy to Professor Samra Turajlic, helping to bridge activi...

Fantastic opportunity from @turajliclab.bsky.social! 🚀

The CanDy Lab is recruiting an Associate Scientist to drive cutting-edge cancer research across @cruk-mi.bsky.social and @crick.ac.uk.

A rare chance to lead, grow, and shape high-impact science 👇
www.cruk.manchester.ac.uk/career/mi-25...

New study uncovers potential way to prevent breast cancer in pre-menopausal women A University of Manchester study funded by Breast Cancer Now and supported by Prevent Breast Cancer, reveals a drug approved for use in other conditions could be repurposed to prevent breast cancer in...

So proud of my colleague Sacha Howell on this latest @nature.com publication reporting on the Breast Cancer-Anti-Progestin Prevention Study 1 (BC-APPS1) - many years in the making: www.nature.com/articles/s41...

Press release from The University of Manchester:
www.manchester.ac.uk/about/news/n...

The UK’s first one-stop kidney cancer clinic at @cuh.nhs.uk is transforming kidney cancer diagnosis. With a confocal microscope, patients can get a biopsy, diagnosis & treatment plan – all on the same day.

Find out more: crukcambridgecentre.org.uk/news/one-sto...

@crukcamurol.bsky.social

Health trends and variation in England 2025: a Chief Medical Officer report An overview of the health of England’s population, including trends over time and geographical variation.

New CMO report out today on health trends and variation in England. My team delivered this using a RAP developed in R, which made a nice change from lots of people running around putting numbers into excel then pasting into powerpoint... Was not without challenges though! www.gov.uk/government/p...

1/2 With #WorldCancerResearchDay shining a light on cancer care, we update on the HQIP-commissioned National Cancer Audit Collaborating Centre, which hosts all ten #NHS national cancer audits that are part of the National Clinical Audit and Patient Outcomes Programme.
@natcan-news.bsky.social

Our new website is live! 🎉

All 10 national cancer audits are now in one place: bowel, OG, NHL, lung, ovarian, kidney, prostate, pancreatic, primary breast & metastatic breast.

Plus refreshed QI & new sections have been added, check it out here 👉 natcan.org.uk

ICYMI and want to know more about how tumor transcription-wide expression classifiers predict treatment sensitivity in advanced prostate cancers > look no further: www.cell.com/cell/pdf/S00...

Thank you Nima!

Scientific Paper Published in Cell, titled: Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers. Written by Grist et al.

Could transcriptome signatures identify men with advanced #ProstateCancer most likely to benefit from chemotherapy?

A brilliant team led by Prof Gerhardt Attard @ucl.ac.uk share exciting new findings in @cp-cell.bsky.social.

Grab a ☕ and read: doi.org/10.1016/j.ce...

Molecular test personalises prostate cancer treatment Testing the molecular profile of tumours identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit f...

A new test can identify which prostate cancer patients are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit from unpleasant side effects, shows a new study led by Prof Gert Attard & Dr Emily Grist @uclmedsci.bsky.social
www.ucl.ac.uk/news/2025/au...

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers Advanced prostate cancers respond to hormone therapy but outcomes vary and no predictive tests exist for informed treatment selection. To identify nov…

REALLY thrilled to share findings from my postdoc work in the Attard lab, which form part of this www.sciencedirect.com/science/arti....

Thanks to Emily and Gert for seeing it over the line, all the funders, the Veracyte, MRC CTU & STAMPEDE teams, and patients who contributed samples. Pls share!

Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation Objective To evaluate the area-based incidence of metastatic prostate cancer at diagnosis, reflecting the risk of late-stage diagnosis, and overall prostate cancer incidence, reflecting the risk of ov...

📢 Start your week with the latest National Prostate Cancer Audit study.

We found that the annual rate of metastatic prostate cancer at diagnosis was more than 60% higher in some regions than in others in England.

Paper link here 👉 bmjoncology.bmj.com/content/4/1/...

National data service will simplify access to health data for research | Wellcome Wellcome is partnering with the UK Government to establish a £600 million health data research service. It will simplify secure access to health data for research.

NEW - Wellcome and UK Government partnering on a new health data research service, contributing up £600m together.

This will simplify secure access to health data and speed up research to better understand ill health.

wellcome.org/news/nationa...

Excellent video about CAcTUS trial combining many aspects of #CancerResearch in #Manchester - including #immunotherapy, #melanoma research & #LiquidBiopsies - #ctDNA

Great to hear @beckilee.bsky.social - formerly of this parish - speak about her work, plus a moving account from patient Kathy Heaton

What are the unique features, outputs and the future of NATCAN (National Cancer Audit Collaborating Centre, @natcan-news.bsky.social), where I manage the prostate @npca-natcan.bsky.social and kidney cancer audits @nkca-natcan.bsky.social?

The answers are here www.sciencedirect.com/science/arti...

Congratulations Anna, fantastic news!

openRxiv has arrived!

We’re thrilled to announce the launch of openRxiv as an independent, researcher-led nonprofit to oversee bioRxiv and medRxiv, the world’s leading preprint servers for life and health sciences.
openrxiv.org/introducing-...

#openRxiv #OpenScience #Preprints #bioRxiv #medRxiv

⚠️Do you or someone you know want to come and work with me and the fantastic @npca-natcan.bsky.social @natcan-news.bsky.social teams based @collegeofsurgeons.bsky.social? Our oncological clinical lead is the super @alison-tree.bsky.social 😁.

Interested? Apply here www.jobs.ac.uk/job/DMB374/c...